![David M. Gravett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David M. Gravett
Keine laufenden Positionen mehr
Karriereverlauf von David M. Gravett
Ehemalige bekannte Positionen von David M. Gravett
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Carbylan Therapeutics, Inc.
![]() Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2007 | 15.04.2016 |
Angiotech Pharmaceuticals, Inc.
![]() Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01.01.2004 | - |
Pasteur Mérieux Connaught | Corporate Officer/Principal | - | - |
Ausbildung von David M. Gravett
University of Toronto | Doctorate Degree |
Statistik
International
Kanada | 3 |
Südafrika | 2 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 2 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Angiotech Pharmaceuticals, Inc.
![]() Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
University of Natal | Consumer Services |
Carbylan Therapeutics, Inc.
![]() Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | Health Technology |
Pasteur Mérieux Connaught |
- Börse
- Insiders
- David M. Gravett
- Erfahrung